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Background: The intricate interactions between the immune, endocrine and central nervous systems shape the
innate immune response of the brain. We have previously shown that estradiol suppresses expression of immune
genes in the frontal cortex of middle-aged ovariectomized rats, but not in young ones reflecting elevated
expression of these genes in middle-aged, ovarian hormone deficient animals. Here, we explored the impact of
menopause on the microglia phenotype capitalizing on the differential expression of macrophage-associated genes
in quiescent and activated microglia.
Methods: We selected twenty-three genes encoding phagocytic and recognition receptors expressed primarily in
microglia, and eleven proinflammatory genes and followed their expression in the rat frontal cortex by real-time
PCR. We used young, middle-aged and middle-aged ovariectomized rats to reveal age- and ovariectomy-related
alterations. We analyzed the expression of the same set of genes in the postcentral and superior frontal gyrus of
pre- and postmenopausal women using raw microarray data from our previous study.
Results: Ovariectomy caused up-regulation of four classic microglia reactivity marker genes including Cd11b, Cd18,
Cd45 and Cd86. The change was reversible since estradiol attenuated transcriptional activation of the four marker
genes. Expression of genes encoding phagocytic and toll-like receptors such as Cd11b, Cd18, C3, Cd32, Msr2 and
Tlr4 increased, whereas scavenger receptor Cd36 decreased following ovariectomy. Ovarian hormone deprivation
altered the expression of major components of estrogen and neuronal inhibitory signaling which are involved in
the control of microglia reactivity. Strikingly similar changes took place in the postcentral and superior frontal gyrus
of postmenopausal women.
Conclusions: Based on the overlapping results of rat and human studies we propose that the microglia phenotype
shifts from the resting toward the reactive state which can be characterized by up-regulation of CD11b, CD14,
CD18, CD45, CD74, CD86, TLR4, down-regulation of CD36 and unchanged CD40 expression. As a result of this shift,
microglial cells have lower threshold for subsequent activation in the forebrain of postmenopausal women.
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The intricate interactions between the immune, endo-
crine and central nervous systems shape the immune re-
sponse within the brain [1-3]. The ovarian hormone
17β-estradiol (E2) exerts potent immunomodulatory
effects in neuroinflammatory models [3-7]. Both neurons
[8] and glial cells [9] express the two classical estrogen
receptors (ER), ERα and ERβ, which mediate the neuro-
protective [10,11] and anti-inflammatory [6,12] activities
of E2. Progesterone and its metabolite allopregna-
nolone exert estrogen-modifying and immunomodula-
tory effects in injury [13,14] and inflammatory [15]
models. We have previously shown that E2 suppresses
the expression of genes associated with the innate im-
mune system in the frontal cortex of middle-aged ovar-
iectomized (OVX) rats [16]. E2-regulated immune genes
encode MHC class I and class II (RT1-Aw2, Cd74), Fcγ
receptors (Fcgr2a, Fcgr2b), and complement proteins
(C3, C4b). In contrast, E2 has no effect on the expres-
sion of the same set of genes in the same region of
young OVX rats [17] reflecting elevated expression of
these immune genes in the frontal cortex of middle-
aged, ovarian hormone-deficient rats. This notion is sup-
ported by the results of human [18-20] and rodent
[21,22] microarray studies demonstrating up-regulation
of immune genes in the cerebral cortex during the
course of normal aging. Up-regulation of MHC class I
and class II, toll-like receptor, complement and cytokine
genes has been shown to be a characteristic feature
of aging in both sexes, with proportionally higher
expression in women indicating sexually dimorphic
changes [20].
In this study, we explored the impact of menopause
on the expression of genes related to the innate immune
system in the rat and human cerebral cortex. We fo-
cused on the potential alteration of the microglia pheno-
type as microglial cells play pivotal roles in the initiation
and regulation of the immune response. It is important
to note that in the adult brain, there is no exchange of
microglial cells under physiological conditions [23-25].
We took advantage of the differential expression of
macrophage-associated genes in resting and activated
microglia [25-28]. Although the microglial response is
signal-specific, activated microglia unfold strong macro-
phage characteristics and express elevated levels of
phagocytic [29], scavenger [30] and toll-like [31] recep-
tors (Tlrs), MHC antigens [32]. Previous studies have
established that in the case of macrophage-associated
genes, mRNA expression correlates well with protein
expression [27,33]. Therefore, we selected thirty-four
genes including twenty-three macrophage-associated
and eleven complement and cytokine genes, and ana-
lyzed their mRNA expression by real-time PCR. We
found up-regulation of several macrophage-associatedand some complement genes in the frontal cortex of
middle-aged OVX rats. To demonstrate the relevance of
these observations to human menopause, we analyzed
the expression of the same set of genes using raw micro-
array data from the postcentral gyrus and superior
frontal gyrus of pre- and postmenopausal women [20].
Data analysis revealed changes highly similar to the ones
we observed in the rat menopausal model. Based on
these results we characterized the microglia phenotype
in the forebrain of postmenopausal women.Methods
Reagents
E2 was purchased from Sigma (St. Louis, MO, USA).
Alzet osmotic minipumps (model 2004) were obtained
from Durect (Cupertino, CA, USA). Microfluidic cards,
PCR and reverse transcription reagents were ordered
from Applied Biosystems (Foster City, CA, USA).Experimental animals and treatments
Female Harlan-Wistar rats were purchased from Toxicoop
(Budapest, Hungary). Animals were housed individually on
a 12-h light/12-h dark cycle, with unrestricted access to
phytoestrogen-free rodent diet (Harlan Teklad Global
Diets, Madison, WI, USA). We applied four rat models:
young adult, 2 month-old rats with low E2 levels (Y group),
middle-aged, 13-month old intact female rats (M group),
middle-aged OVX rats (M/OVX group), and middle-aged
OVX rats with chronic E2 treatment (M/OVX+E2 group).
For the young adult group we chose young OVX rats, since
ovariectomy did not result in changes of macrophage-
associated genes, as we reported earlier addressing the
effect of E2 treatment in this model [17]. Bilateral ovariec-
tomy of young (n = 10) and middle-aged (n = 20) rats was
performed under deep anesthesia. Animals in the M group
(n = 9) were sham-operated. After surgery, rats were
housed individually and ten days later, received treatments
with vehicle. E2 replacement in middle-aged OVX rats
was carried out as described earlier [16].
On the day of sample preparation, animals were deeply
anesthetized and perfused transcardially with 100 ml of
cold fixative solution containing 10% RNAlater in
phosphate-buffered saline. In all experiments, the same
procedure was followed for the preparation of the frontal
cortex as published earlier [17]. Protocols were reviewed
and approved by the Animal Welfare Committee of the
Institute of Experimental Medicine (Number A5769-01,
permission from the Department of Epidemiology and
Animal Welfare, Municipal Agriculture Office, Budapest,
Hungary). Experiments were carried out in accordance
with the legal requirements of the European Community
(Decree 86/609/EEC).
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Total RNA was isolated from cortical samples using the
RNeasy Lipid Tissue Mini Kit (Qiagen, Hilden,
Germany). RNA analytics included A260nm/A280nm
readings using a Nanodrop Spectrophotometer and ca-
pillary electrophoresis using RNA Nano Chips with the
2100 Bioanalyzer (Agilent, Santa Clara, CA, USA). All
RNA samples displayed RNA integrity numbers
above 8.2.
Quantitative real-time PCR
Custom TaqMan low density arrays (TLDA) were
designed to study in depth the regulation of thirty-four
macrophage-associated and immune genes by quantitative
real-time PCR. Microfluidic cards (Applied Biosystems,
Santa Clara, CA, USA) were preloaded by the manufac-
turer with selected inventoried assays for the genes of our
interest (Table 1) and for five potential house-keeping
genes including 18S rRNA, glyceraldehyde-3-phosphate
dehydrogenase (Gapdh), glucuronidase beta (Gusb), hypo-
xanthine guanine phosphoribosyl-transferase (Hprt) and
peptidyl-prolyl isomerase A (Ppia). Each assay consisted of
a FAM dye-labeled TaqMan MGB probe and two PCR
primers. Reverse transcription and real-time PCR were
run as described earlier [16]. The RealTime StatMiner
(Integromics, Granada, Spain) software and relative quan-
tification against calibrator samples (ΔΔCt) were used for
analysis. To find the most stable endogenous controls, the
normfinder stability scoring method [34] was used. A
computed internal control corresponding to the geometric
mean of cycle threshold (Ct) values of selected house-
keeping genes was used for ΔCt calculation [35].
Analysis of human microarray data
Files [GEO: GSE11882] [20], contained microarray data
from four regions of the forebrain: postcentral gyrus
(PG), superior frontal gyrus (SG), entorhinal cortex,
hippocampus. As menopause occurs between 50 and 53
years of age [36,37], this analysis included female cases
divided into two age groups. The first group consisted of
the putatively premenopausal subjects between 25 and
50 years of age, the second included postmenopausal
women between 60 and 78 years of age. Importantly, we
excluded subjects above 80 years of age since at this time
significant age-related alterations occur in the cortical
transcriptome. From the data set, we analyzed PG and SG,
which were relevant to compare with the rat frontal cor-
tex. Sample size (n), average age (age) in years and stand-
ard deviation of age (SD) were used to characterize the
premenopausal PG (nPG = 7, agePG = 38.9, SDPG = 7.9)
and SG (nSG = 10, ageSG = 39.1, SDSG = 7.6), and postme-
nopausal PG (nPG = 5, agePG = 71.2, SDPG = 4.4) and SG
(nSG = 6, ageSG = 71.7, SDSG = 4.1) data. Raw microarray
data were pre-processed for analysis by GC robustmulti-array average (GCRMA) [38]. From the expres-
sion set, probesets were selected based on the rele-
vance to rat data. After annotation, we identified
twenty-nine human genes with high confidence
(Table 2). Difference analysis of gene expression was
performed by linear models combined with empirical
Bayesian methods [39]; P was adjusted by the false dis-
covery rate-based method [40]. In all statistical and
data mining work, Bioconductor packages [41] in
R-environment were used.
Results
Age and ovarian hormone deficiency led to elevation in
mRNA expression of Cd11b, Cd18, Cd45, Cd74 and Cd86
in the frontal cortex of middle-aged female rats
We explored the impact of ovarian hormone deficiency
on mRNA expression of six genes encoding the alpha
and beta chain of complement receptor (CR) type 3
(Cd11b and Cd18), TNF receptor superfamily member 5
(Cd40), leukocyte common antigen (Cd45), MHC class
II-associated invariant chain (Cd74) and B72 antigen
(Cd86). These receptors are widely considered as mar-
kers of microglia reactivity [25,27]. As a result of ovari-
ectomy, we found a 1.5- to 2.0-fold increase in mRNA
expression of Cd11b (Figure 1A), Cd18 (Figure 1B),
Cd45 (Figure 1D) and Cd86 (Figure 1F). Other markers
such as Cd40 (Figure 1C) and Cd74 (Figure 1E) did not
change.
We determined age-related changes in the expression
of these marker genes by comparing middle-aged rats to
young ones. As a result of aging, we found a 1.4-fold en-
hancement in Cd11b (Figure 1A), 2.0-fold increase in
Cd74 (Figure 1E) and 1.2-fold elevation in the other four
genes. In the case of Cd11b, Cd18, Cd45 and Cd86,
ovarian hormone deficiency-related alterations exceeded
age-related ones underscoring the importance of ovarian
hormones on microglial gene expression. Altogether, age
and ovarian hormone deficiency resulted in an average
of 2.0-fold elevation in the expression of the marker
genes, with the exception of Cd40 (Table 1). It is note-
worthy that Nos2 was not induced (Table 1).
We studied the effect of E2 replacement on the
ovariectomy-dependent increase of marker genes. E2
attenuated the enhancement of Cd11b, Cd18, Cd45 and
Cd86 (Figure 1). These results indicated that alterations
in the expression of microglia marker genes were revers-
ible, at least in part, following ovariectomy.
Ovariectomy-dependent changes in the expression of
genes related to phagocytosis
In addition to Cd11b and Cd18, we examined age- and
ovariectomy-related alterations in the expression of Fcγ
receptor 2a (Cd32), phagocytic C1q receptor (Cd93),
macrophage scavenger receptor 2 (Msr2) and leukocyte
Table 1 Age- and ovarian hormone-related changes in expression of genes related to microglial reactivity in the
frontal cortex of middle-aged female rats
Symbol Taqman assay ID RQ (age) P (age) RQ (OVX) P (OVX) RQ (age+OVX) P (age+OVX)
Macrophage-associated genes
Phagocytic and scavenger receptors
Cd11bb Rn00709342_m1 1.389a 0.044 2.000a < 0.001 2.778a < 0.001
Cd18b Rn01427948_m1 1.206 1.488a 0.001 2.164a < 0.001
Cd93 Rn00584525_g1 1.271 0.082 0.796 0.051 1.012
Fcgr2b Rn00598391_m1 1.560a 0.024 1.595a < 0.001 2.488a < 0.001
Msr2 Rn01455191_m1 2.630 1.353a 0.025 3.558a 0.003
Cd36 Rn00580728_m1 0.567a <0.001 0.776a 0.012 0.440a < 0.001
Rage Rn00584249_m1 1.225 0.870 1.066
Recognition receptors
Cd14 Rn00572656_g1 0.844 1.391 1.174
Cd40b Rn01423590_m1 1.496 0.087 0.990 1.481 0.054
Cd45b Rn00709901_m1 1.196 1.504a < 0.001 1.799a < 0.001
Cd86b Rn00571654_m1 1.178 1.513a 0.001 1.782a < 0.001
Tlr2 Rn02133647_s1 1.015 1.000 1.015
Tlr4 Rn00569848_m1 1.207 1.253a 0.006 1.512a < 0.001
Tlr9 Rn01640054_m1 1.452a 0.033 1.348 1.907a 0.008
RT1-Aw2 Rn03034964_u1 14.696a < 0.001 1.479a 0.001 21.735a < 0.001
RT1-N1 Rn00561858_m1 0.588a 0.046 3.300a < 0.001 1.941a < 0.001
Cd74 Rn00565062_m1 2.379a 0.031 0.948 2.255a 0.047
Signaling
Nos2 Rn00561646_m1 0.971 1.072 1.041
Irf7 Rn01450778_g1 1.855 2.519a < 0.001 4.748a < 0.001
Irf9 Rn01489163_m1 1.332a 0.030 1.311a 0.004 1.746a < 0.001
Regulatory genes for microglia reactivity
Microglial receptors
Cd47 Rn00569914_m1 0.884 0.084 1.189a 0.041 1.051
Cd200r Rn00576646_m1 0.821a 0.005 0.880 0.069 0.722a < 0.001
Cx3cr1 Rn00591798_m1 1.375a 0.006 0.975 1.341a 0.005
Neuronal ligands
Cd200 Rn00580478_m1 0.945 0.878 0.088 0.829a 0.019
Sirpa Rn00564609_m1 0.922 1.071 0.987
Cx3cl1 Rn00593186_m1 0.928 0.813a < 0.001 0.754a < 0.001
Complement and cytokine genes
Complement
C1qb Rn00570480_m1 1.739a < 0.001 0.951 1.654a < 0.001
C1-Inh Rn01485600_m1 1.008 1.541a 0.005 1.553a 0.009
C3 Rn00566466_m1 4.297a < 0.001 1.193a 0.010 5.126a < 0.001
Chemokine and cytokines
Ccl2 Rn00580555_m1 1.294 1.634a 0.079 2.114a 0.014
Il1b Rn00580432_m1 2.390a < 0.001 0.518a <0.001 1.238
Il6 Rn00561420_m1 1.119 0.651 0.728
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Table 1 Age- and ovarian hormone-related changes in expression of genes related to microglial reactivity in the
frontal cortex of middle-aged female rats (Continued)
Tgfb1 Rn00572010_m1 0.898 0.057 1.500a < 0.001 1.347a < 0.001
Tnf Rn99999017_m1 0.843 1.595 0.084 1.345
Quiescent and activated microglial cells differ strikingly in the expression of macrophage-associated genes. Age- and ovariectomy-related changes in mRNA
expression were measured by real-time PCR. The applied TaqMan assays were listed. RQ represents the expression of a given gene in response to aging or
ovariectomy compared to basal (control) expression. RQ (age) represents the ratio of mRNA expression in middle-aged versus young rats. RQ (OVX) shows the
ratio of mRNA levels in middle-aged OVX rats versus middle-aged ones. RQ (age+OVX) values correspond to the ratio of mRNA expression in middle-aged OVX
rats compared to young ones. Statistical significance of the alterations was tested by analysis of variance (ANOVA) with Newman-Keuls post hoc test, and was
considered significant at P < 0.05; aRQ values with statistically significant changes. P-values are indicated if < 0.1. bMicroglial marker genes.
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http://www.jneuroinflammation.com/content/9/1/264differentiation antigen (Cd36). Similar to Cd11b and
Cd18, expression of Cd32 (Figure 2A), Cd93 (Figure 2B)
and Msr2 (Figure 2C) showed a 1.6-, 1.3- and 2.6-fold
age-related increase, respectively. Expression of Cd32
and Msr2 enhanced further, whereas Cd93 expression
decreased 0.8-fold after ovariectomy. Expression of Cd36
dropped 0.6-fold in the aging brain, which decreased fur-
ther following ovariectomy (Figure 2D). Altogether, age
and ovarian hormone deficiency caused 2.5- and 3.6-fold
increase in the expression of Cd32 and Msr2, respect-
ively. In contrast, Cd36 decreased 0.44-fold.
Cd11b/Cd18 and Cd93 recognize C3 activation frag-
ments and C1q, respectively. Messenger RNA expression
of C1q (Figure 2E) and C3 (Figure 2F) increased in the
aging frontal cortex 1.8- and 4.3-fold, respectively. The
robust increase of C3 was amplified further after ovari-
ectomy. Again, E2 reversed the increase of Cd11b, Cd18,
Cd32 and Msr2 expression (Figure 2), which was in good
correlation with the attenuation of Cd45 and Cd86 ex-
pression following ovariectomy (Figure 1).Ovarian hormone deficiency enhanced mRNA expression
of toll-like receptor 4 and 9
Microglial cells express Tlrs and co-receptors to
recognize apoptotic cells, amyloid peptide and bacterial
cell wall components among others [25,42]. Aging led to
a 1.2- to 1.5-fold increase in the expression of Tlr4 and
Tlr9. Ovariectomy caused comparable elevation (Figure 3B
and C). Altogether, age and ovarian hormone deficiency
resulted in 1.5- and 2.0-fold increase in the expression of
Tlr4 and Tlr9. Changes in the expression of Tlr2
(Figure 3A) and Cd14 (Figure 3D) did not reach statistical
significance.
Again, E2 attenuated the increase of Tlr4 and Tlr9 ex-
pression similarly to Cd11b, Cd18, Cd32, Cd45, Cd86
and Msr2.Aging and ovarian hormone deprivation increased mRNA
expression of RT1-Aw2
MHC class I antigens RT1-Aw2 and RT1-N1 showed
significant age- and ovariectomy-related increase in their
expression (Table 1). RT1-Aw2 showed 14.7- and 1.5-
fold age- and ovariectomy-related increase, respectively.Altogether, there was a 21.7-fold increase in mRNA ex-
pression of RT1-Aw2.
Age and ovariectomy altered the expression of genes
involved in the regulation of microglia reactivity
We examined age- and ovarian hormone deficiency-
related alterations of key components of neuronal in-
hibitory pathways and estrogen signaling, which play
a pivotal role in the regulation of microglia reactiv-
ity. Neurons tightly control the reactivity of micro-
glial cells by expressing inhibitory ligands [43]. We
measured expression of six genes encoding neuronal
ligand-microglial receptor pairs such as Cd47-Sirpa,
Cd200-Cd200r and Cx3cl1-Cx3cr1. As a result of
aging and ovariectomy, we found 0.8- to 0.7-fold de-
crease in the expression of Cd200 (Figure 4D) and
Cd200r (Figure 4C). We observed a 0.75-fold de-
crease in Cx3cl1 (Figure 4F), and a 1.3-fold increase
in Cx3cr1 (Figure 4E). There was no change in Cd47
(Figure 4B) and Sirpa (Figure 4A).
We also determined age- and ovarian hormone-
dependent alterations in the expression of Esr1 and Esr2
genes encoding ERα and ERβ, respectively. Both age and
ovarian hormone deficiency altered their expression. Ex-
pression of Esr1 decreased (Figure 5A), whereas Esr2
increased (Figure 5B) during aging. Ovariectomy decreased
the transcription of both receptors. Altogether, aging and
ovariectomy caused a 0.6-fold decrease in Esr1 and a 1.8-
fold increase in Esr2 expression.
E2 replacement ten days after ovariectomy rescued the
transcription of Esr1 and Esr2. These results suggested
that key genes in control mechanisms for microglia re-
activity were altered in the frontal cortex of middle-aged,
ovarian hormone-deprived rats.
Expression of selected cytokines and other immune
genes
We studied the expression of three pro-inflammatory
cytokines (Il1b, Il6, Tnf ) and astrocytic Tgfb1. The
expression of Il1b increased during aging and dropped
after ovariectomy. Tgfb1 did not change during aging,
but was enhanced significantly after ovariectomy. Il6 and
Tnf showed no significant alteration. As a result of aging
and ovariectomy, only Tgfb1 was enhanced 1.3-fold,
Table 2 Data analysis showed alterations in the expression of macrophage-associated, regulatory and proinflammatory
genes in cortical regions of postmenopausal women, indicating overlapping changes with the rat results
Microarray analysis Real-time PCR
Symbol Probeset FC (PG) P * (P G) FC (SG) P * (S G) RQ (age+OVX) P (age+OVX)
Macrophage-associated genes
Phagocytic and scavenger receptors
CD11bb 205786_s_at 1.341 0.918 1.145 0.832 2.778 < 0.001
CD18b 1555349_a_at 2.808a 0.697 2.331a 0.629 2.164 < 0.001
FCGR2b 210889_s_at 1.020 1.000 1.228 0.746 2.488 < 0.001
CD36 228766_at 0.670a 0.942 0.812 0.793 0.440 < 0.001
RAGE 217046_s_at 1.000 1.000 0.991 0.960 1.066
Recognition receptors
CD14 201743_at 5.134a 0.697 2.817a 0.629 1.174
CD40b 205153_s_at 1.025 0.877 0.967 0.881 1.481 0.054
CD45b 212588_at 1.903a 0.918 1.152 0.938 1.799 < 0.001
CD86b 205685_at 1.466 0.697 1.094 0.709 1.782 < 0.001
TLR2 204924_at 1.832a 0.781 1.035 1.000 1.015
TLR4 221060_s_at 1.152 1.000 1.634a 0.629 1.512 < 0.001
TLR9 223903_at 1.182 0.629 1.907 0.008
CD74b 1567628_at 2.232a 0.697 1.631a 0.689 2.255 0.047
Signaling
NOS2 212531_at 0.965 1.000 1.002 1.000 1.041
IRF7 208436_s_at 1.047 1.000 1.341 0.629 4.748 < 0.001
IRF9 203882_at 1.105 1.000 1.242 0.629 1.746 < 0.001
Regulatory genes for microglia reactivity
Microglial receptors
CD200R 1552875_a_at 0.990 0.942 0.990 0.763 0.722 < 0.001
CX3CR1 1568934_at 0.557a 0.967 0.960 1.000 1.341 0.005
Neuronal ligand
CD200 209582_s_at 0.886 1.000 0.497a 0.629 0.829 0.019
SIRPA 202897_at 0.799 0.877 0.908 0.750 0.987
CX3CL1 823_at 0.462a 0.697 0.575a 0.629 0.754 < 0.001
Complement and cytokine genes
Complement
C1q 202953_at 4.364a 0.697 2.319a 0.629 1.654 < 0.001
C1-INH 200986_at 1.419 0.877 1.723a 0.629 1.553 0.009
C3 217767_at 1.577a 0.942 1.246 0.842 5.126 < 0.001
Chemokine and cytokines
CCL2 216598_s_at 1.976a 0.942 2.492a 0.629 2.114 0.014
IL1b 205067_at 0.669 0.984 0.743 0.763 1.238
IL6 205207_at 0.594a 0.907 0.748 0.709 0.728
TGFb1 203085_s_at 1.812a 0.781 1.988a 0.629 1.347 < 0.001
TNF 207113_s_at 1.345
Differential expression of selected genes in the postcentral and superior frontal gyrus of pre- and postmenopausal women. Fold change (FC) corresponds to the
ratio of the older and younger group mean expressions for a given gene. aFC > 1.5; P* false discovery rate-adjusted raw P-value; RQ(age+OVX) values correspond
to the ratio of mRNA expression in middle-aged OVX rats compared to young ones; bconventional microglial marker genes are in bold.
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Figure 1 Age- and hormone-dependent alteration in the mRNA expression of widely used microglia marker genes in the frontal cortex
of middle-aged female rats. Real-time PCR demonstrated age- and ovarian hormone-related increase in the transcription of Cd11b (A), Cd18
(B), Cd45 (D) and Cd86 (F). 17β-estradiol (E2) replacement attenuated these changes. Cd40 (C) and Cd74 (E) expression did not change after
ovariectomy. Error bars show SD of six samples for each group. Statistical significance of the alterations in different groups compared to middle-
aged female rats (M) was analyzed by analysis of variance (ANOVA) with Newman-Keuls post hoc test, and considered significant at P < 0.05.
Asterisks indicate significant changes: *corresponds to 0.01< P <0.05, ** to 0.001< P <0.01 and *** to P < 0.001. Y, young rat; M/OVX, middle-aged
ovariectomized (OVX) rat; M/OVX+E2, middle-aged OVX rat treated chronically with E2.
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did not develop in the ovarian hormone-deprived
aging cortex.
We examined the expression of Ccl2 and found 1.6-
fold ovariectomy-related elevation in its expression,
which was reversed by E2 (Table 1). Irf7 and Irf9, encod-
ing IFN regulatory factors, increased during aging and
intensified further after ovariectomy (Table 1).
Microarray data analysis revealed strikingly similar
changes of gene expression in the postcentral and
superior frontal gyrus of postmenopausal women
To address the impact of menopause on gene expression
in the human forebrain, we carried out an analysis of
raw microarray data from our previous gene expression
profiling study [20]. The expression of twenty-nine genesassociated with the innate immune response was com-
pared in the PG and SG from premenopausal versus
postmenopausal women with an average age of 39 and
71 years, respectively. To identify differentially expressed
genes in small samples, we used the raw FC values, as
FC correlates well with reproducibility [44]. We consid-
ered alterations with FC > 1.5 to be reliable changes.
Our analysis revealed up-regulation of CD14, CD18,
CD45, TLR2, TLR4, CD74, C1q, C3, CCL2, and down-
regulation of CD36, CX3CR1, CX3CL1 and CD200 in
postmenopausal women (Table 2).
Discussion
In this study, we demonstrated that menopause ampli-
fied the age-related increase in the expression of
macrophage-associated genes in the frontal cortex. From
Figure 2 Age- and hormone-related changes in mRNA expression of genes related to phagocytosis. Real-time PCR demonstrated age-
and ovariectomy-related increase in the expression of Cd32 (A), Msr2 (C), C1qb (E), C3 (F), and decrease of Cd93 (B), Cd36 (D). Error bars show SD
of six biological samples. Statistical significance of the alterations in different groups compared to middle-aged female rats (M) was analyzed
using analysis of variance (ANOVA) followed by Newman-Keuls post hoc test. Asterisks indicate changes with statistical significance: *corresponds
to 0.01< P < 0.05, ** to 0.001< P < 0.01 and *** to P < 0.001. Y, young rat; M/OVX, middle-aged ovariectomized (OVX) rat; M/OVX+E2, middle-
aged OVX rat with 17β-estradiol (E2) replacement.
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phenotype shifts from the resting towards the activated
state in a rat model of menopause, ii) the shift is revers-
ible, iii) altered expression of phagocytic receptors may
indicate modified phagocytic activity, iv) impairment of
regulatory mechanisms may contribute to the early state
of microglia activation, and v) strikingly similar changes
occur in the forebrain of postmenopausal women.
The microglia phenotype shifts from the resting toward
the activated state in the frontal cortex of middle-aged
ovariectomized rats
Slight up-regulation of Cd11b, Fcgr2b, Tlr9, RT1-Aw2,
and Cd74 in the frontal cortex of middle-aged rats indi-
cates an initial age-related alteration in microglial gene
expression. Elevated expression of C1q, C3 and Il1b is inaccord with previous studies [18-22]. As these genes are
expressed in astrocytes and microglia, it is likely that
changes of glial phenotypes are intertwined. It is worth
noting that the expression of C1-Inh, encoding the sole
regulator of the classical activation pathway [45], does
not change, suggesting that the control of the classical
pathway may be impaired.
Ovarian hormone deficiency enhanced the expression
of Cd11b, Cd18, Cd32, Cd45, Cd86, Tlr4, RT1-Aw2, and
decreased Cd36, reflecting an initial shift in the micro-
glia phenotype. The increase in the expression of IFN
regulatory factors Irf7 and Irf9 is in accord with the shift
of microglia from the resting phenotype [46]. Down-
regulation of Cd36 [47] is also a characteristic feature of
the acquired microglia phenotype. We suggest that
down-regulation of Cd36 may underlie the decreased
Figure 3 Age- and ovarian hormone-dependent regulation of genes encoding toll-like receptors and co-receptor Cd14 in the rat
frontal cortex. TaqMan-based quantitative real-time PCR revealed changes in mRNA expression of Tlr4 (B) and Tlr9 (C). Tlr2 (A) and Cd14 (D) did
not alter. Error bars show SD of six independent measurements. Statistical significance of the alterations in different groups compared to middle-
aged female rats (M) was calculated using analysis of variance (ANOVA) with Newman-Keuls post hoc test, and considered significant at P < 0.05.
Asterisks indicate changes with statistical significance: * corresponds to 0.01< P < 0.05, ** to 0.001< P < 0.01 and *** to P < 0.001. Y, young rat;
M/OVX, middle-aged ovariectomized (OVX) rat; M/OVX+E2, middle-aged OVX rat treated with 17β-estradiol (E2).
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microglia [48].
Our human microarray data analysis identified strik-
ingly similar changes. Based on these results we propose
that in the PG and SG of postmenopausal women the
microglia phenotype is characterized by the up-
regulation of CD11b, CD14, CD18, CD45, CD74, CD86,
TLR4, and down-regulation of CD36. Notably, the ex-
pression of CD40 and NOS2 does not change.
The effect of E2 indicates that the shift in microglia
phenotype is reversible
E2 replacement attenuated the ovarian hormone
deprivation-related increase in the expression of Cd11b,
Cd18, Fcgr2b, Msr2, Cd45, Cd86, Tlr4, RT1-Aw2 and
RT1-N1. Down-regulation of these macrophage-associated
genes suggests that E2 may attenuate microglial activation.
This notion is consistent with the regulatory role of E2 on
macrophage functions [49] and microglia activation in in-
flammatory [12,50] and injury [51] models.
Complement-mediated phagocytosis may increase in the
middle-aged cortex
Age-dependent elevation takes place in the expression of
C1q, and its phagocytic receptor CD93 in the frontal cortex
of female rats. C1q binds to pathogens and apoptotic cells,
directly or through antibodies and pentraxins [45]. C1qbinding initiates the classical pathway of complement result-
ing in recruitment of phagocytes, phagocytosis of apoptotic
cells and destruction of invading pathogens. In the brain
C1q also recognizes and binds to proteins with pathogenic
conformation, such as amyloid-β and prion protein. Elevated
expression of C1q may facilitate early recognition and
phagocytosis of pathogenic substances in the aging brain.
C3 is the central component of the complement system
[45]. Activation pathways converge at C3, and its proteolytic
fragments are ligands for complement receptors on various
cell types including microglia. The interaction between C3
fragment iC3b and CR3 links complement activation and
phagocyte functions. In the presence of C3 activators, ele-
vated expression of C3 and CR3 may contribute to early
steps of microglia activation, often referred to as microglial
priming [2]. This notion is supported by the co-localization
of C3b fragments and activated microglia in humans and in
rodent models of neuroinflammatory diseases [52-54]. The
impact of the interaction between C3 fragments and CR3
on microglia priming has been recently demonstrated in a
multiple sclerosis model [54].
Neuronal inhibitory pathways and estrogen signaling are
altered after menopause
Neuronal inhibitory ligands play a pivotal role in the tight
control of microglia reactivity [24,43]. We demonstrated
age- and ovariectomy-related alterations in the expression
Figure 4 Age- and ovarian hormone-dependent regulation of genes encoding microglial receptors and their inhibitory neuronal
ligands in the rat frontal cortex. TaqMan-based quantitative real-time PCR revealed no change in Sirpa (A), increase in the expression Cd47 (B),
decrease in mRNA expression of Cd200r (C), Cd200 (D) and Cx3cl1 (F). Cx3cr1 (E) increased during aging. Error bars show SD of six independent
measurements. Statistical significance of the alterations in different groups compared to middle-aged female rats (M) was determined by analysis
of variance (ANOVA) with Newman-Keuls post hoc test, and considered at P <0.05. Asterisks indicate changes with statistical significance:
*corresponds to 0.01< P < 0.05, ** to 0.001< P < 0.01 and *** to P < 0.001. Y, young rat; M/OVX, middle-aged OVX rat; M/OVX+E2, middle-aged
ovariectomized (OVX) rat treated with 17β-estradiol (E2).
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http://www.jneuroinflammation.com/content/9/1/264of inhibitory ligands, including down-regulation of Cx3cl1
and Cd200, and up-regulation of Cd47 in the frontal cor-
tex of middle-aged rats. The expression of microglial
receptors for these ligands also showed changes, includ-
ing down-regulation of Cd200r and up-regulation of
Cx3cr1. Decreased expression of Cd200r is in accord
with the age-related decrease in the expression of
CD200R protein in the mouse brain [55]. CD200 fusion
protein decreases microglia activation in the hippocam-
pus of aged rats [56]. These data suggest that decreased
expression of Cd200 and Cd200r may contribute to the
increased expression of macrophage-associated genes. In
the PG and SG of postmenopausal women, down-
regulation of CD200 and CX3CL1 also indicates theimpairment of major regulatory mechanisms for the
control of microglia reactivity.
Estrogen signaling is also involved in the regulation of
microglia reactivity [4,50]. Direct regulation is supported
by the presence of ERα and ERβ in microglial cells [9]
and by the well-known effects of E2 on macrophages
[49]. However, ERα and ERβ are also expressed in neu-
rons, astrocytes [57], and oligodendrocytes [58], so the
role of indirect effects cannot be ruled out either. Here,
we provide evidence for inverse age-related regulation of
ERα and ERβ. Decreased expression of ERα together
with the declining levels of E2 is likely to reduce estro-
gen signaling in the aging rat cortex following ovariec-










































Figure 5 Age- and ovarian hormone-dependent regulation of mRNA expression of estrogen receptors in the rat frontal cortex. We
measured age- and hormone-dependent changes by TaqMan-based quantitative real-time PCR in mRNA expression of Esr1 (A) and Esr2 (B),
encoding ERα and ERβ, respectively. Error bars show SD of six independent measurements. Asterisks indicate changes with statistical significance:
*corresponds to 0.01< P < 0.05, ** to 0.001< P < 0.01 and *** to P < 0.001. Y, young rat; M, middle-aged female rat; M/OVX, middle-aged
ovariectomized (OVX) rat; M/OVX+E2, middle-aged OVX rat with 17β-estradiol (E2) replacement.
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http://www.jneuroinflammation.com/content/9/1/264and ESR2 expression in the forebrain of postmenopausal
women.
Summing up, the results provide evidence for micro-
glial activation in the cortex of middle-aged rats follow-
ing surgical menopause. Based on the overlapping
changes from rodent and human studies, we propose that
in the forebrain of postmenopausal women the microglia
phenotype shifts from the resting towards the reactive
state, which is characterized by up-regulation of CD11b,
CD18, CD45, CD74, CD86, TLR4, down-regulation of
CD36 and unchanged CD40 expression. This early state
of activation, called microglial priming, seems to be re-
versible, as E2 replacement attenuates the expression of
macrophage-associated genes in the rat frontal cortex.
Microglia priming results in a phenotype with a lower
threshold for subsequent activation [2,59]. It is proposed
that in the presence of primed microglia, systemic infec-
tion and inflammation pose a higher threat for the aging
brain [59].
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